Anti-Human CD40 Recombinant Antibody(Lucatumumab)
-
产品编号
YR1112
-
别名
科研级 Lucatumumab ( 卢卡木单抗 ), Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Lucatumumab ( 卢卡木单抗 ), Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab |
| Catalog Number | YR1112 |
| Molecular Name | Lucatumumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Lucatumumab (CHIR 12.12 or HCD122) is a human monoclonal antibody against CD40 development of which was discontinued by Novartis in 2013 after it was investigated for the treatment of various types of cancer like multiple myeloma and follicular lymphoma. |
| CAS Number | 903512-50-5 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD40[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
